Nearly 2/3 of solid tumors carry at least one mutation that may be targeted by existi

[News]

Nearly two-thirds of solid tumors carry at least one mutation that may be targeted, or medicated, by an existing compound, according to new findings from researchers Fox Chase Cancer Center that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology on June 3.

More... (http://www.news-medical.net/news/20130601/Nearly-23-of-solid-tumors-carry-at-least-one-mutation-that-may-be-targeted-by-existing-compound.aspx)